- Genuine Parts Co (NYSE:GPC) reported second-quarter FY22 sales growth of 17.1% year-on-year, to $5.60 billion, beating the consensus of $5.29 billion.
- The company attributed the sales growth to an 11.5% increase in comparable sales and an 8.8% benefit from acquisitions.
- Automotive Group sales grew 8.5% Y/Y. This segment’s profit margin increased 20 basis points to 9.3%.
- Sales for the Industrial Parts Group rose 34.5%, and the segment’s profit margin expanded 110 basis points to 10.6%.
- Adjusted EPS of $2.20 beat the analyst consensus of $2.02.
- Gross profit increased 16% Y/Y to $1.96 billion.
- Selling, administrative and other expenses were $1.4 billion, a 1.1% rise Y/Y.
- Cash and equivalents totaled $519.1 million as of June 30, 2022.
- “We are benefiting from the resiliency of our Automotive and Industrial businesses and the strategic mix of our operations,” said Chairman and CEO Paul Donahue.
- Outlook: Genuine parts raised FY22 revenue growth guidance to 12% – 14% versus the prior outlook of 10% – 12%.
- It raised the FY22 adjusted EPS outlook to $7.80 – $7.95 from $7.70 – $7.85 versus the consensus of $7.83.
- Price Action: GPC shares traded higher by 1.28% at $144.55 on the last check Wednesday.
Related Posts
Recap: Holley Q1 Earnings
Holley (NYSE:HLLY) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:30 AM. Here’s what investors…
Novartis Presents New Long-Term Leqvio Data Demonstrating Consistent Efficacy And Safety Beyond Six Years
Results from the ORION-8 open-label extension trial show twice-yearly* Leqvio, in addition to statin therapy, provides consistent low-density lipoprotein cholesterol (LDL-–C) reduction beyond six years of treatment1
Eight in ten patients achieved target LDL-C threshold**, in line with previously reported Phase III data1-3
(MSI) – Analyzing Motorola Solns’s Short Interest
Motorola Solns’s (NYSE:MSI) short percent of float has fallen 3.9% since its last report. The company recently reported…